Zerbaxa Injection, Powder, Lyophilized, For Solution
Product Images NDC 67919-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zerbaxa (NDC 67919-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zerbaxa 01)

FDA Label Image

Chemical Structure (Zerbaxa 02)

FDA Label Image

Principal Display Panel (10 Vial Carton)

Principal Display Panel (10 Vial Carton)
Zerbaxa is a ceftolozane and tazobactam injection intended for intravenous infusion. The drug must be kept refrigerated in its carton until use. Each vial contains 1 gram of ceftolozane sulfate equivalent to 1147 grams of ceftolozane and 0.5 grams of tazobactam sodium equivalent to 0.537 grams of tazobactam. The remaining text contains various codes and marks and is not a useful description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.